Kevin Bruce Yankton Twist Bioscience Corp (TWST) insider trading activity

Kevin Bruce Yankton is Chief Accounting Officer of Twist Bioscience Corp. Currently has a direct ownership of 9,115 shares of TWST, which is worth approximately $439,069. The most recent transaction as insider was on May 17, 2023, when has been sold 70 shares (Common Stock) at a price of $12.98 per share, resulting in proceeds of $908. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.12K

0% 3M change

0% 12M change

Total Value Held $439,069

Kevin Bruce Yankton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 17 2023	SELL Payment of exercise price or tax liability	$908 $12.98 p/Share	70 Reduced 0.76%	9,115 Common Stock
Apr 10 2023	SELL Payment of exercise price or tax liability	$1,040 $16.51 p/Share	63 Reduced 0.68%	9,185 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$1,131 $15.08 p/Share	75 Reduced 0.74%	9,998 Common Stock
Feb 17 2023	SELL Payment of exercise price or tax liability	$1,351 $22.52 p/Share	60 Reduced 0.59%	10,073 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$1,785 $23.81 p/Share	75 Reduced 0.73%	10,133 Common Stock
Dec 20 2022	SELL Payment of exercise price or tax liability	$7,752 $35.24 p/Share	220 Reduced 2.11%	10,208 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	2,903 Added 24.54%	8,928 Common Stock
Nov 17 2022	SELL Payment of exercise price or tax liability	$1,524 $25.4 p/Share	60 Reduced 0.99%	6,025 Common Stock
Sep 30 2022	SELL Payment of exercise price or tax liability	$2,220 $35.24 p/Share	63 Reduced 1.02%	6,085 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	-	1,500 Added 12.58%	10,428 Common Stock
Aug 17 2022	SELL Payment of exercise price or tax liability	$2,897 $48.29 p/Share	60 Reduced 0.97%	6,148 Common Stock
Jul 01 2022	SELL Payment of exercise price or tax liability	$2,373 $37.08 p/Share	64 Reduced 1.02%	6,208 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$7,969 $33.91 p/Share	235 Reduced 3.61%	6,272 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$3,545 $52.91 p/Share	67 Reduced 1.02%	6,507 Common Stock
Feb 09 2022	SELL Payment of exercise price or tax liability	$5,804 $77.39 p/Share	75 Reduced 1.13%	6,574 Common Stock
Dec 27 2021	BUY Grant, award, or other acquisition	-	3,448 Added 34.15%	6,649 Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	-	1,600 Added 33.33%	3,201 Common Stock

Also insider at

VREX

Varex Imaging Corp Healthcare

Chief Accounting Officer

KBY